Hypoxia Increases ATX Expression by Histone Crotonylation in a HIF-2α-Dependent Manner
暂无分享,去创建一个
[1] V. Aidinis,et al. Autotaxin in Breast Cancer: Role, Epigenetic Regulation and Clinical Implications , 2022, Cancers.
[2] Hwan-Woo Park,et al. Discoidin Domain Receptor 2 Mediates Lysophosphatidic Acid-Induced Ovarian Cancer Aggressiveness , 2021, International journal of molecular sciences.
[3] Ziqiang Wang,et al. Histone crotonylation-centric gene regulation , 2021, Epigenetics & chromatin.
[4] K. Harper,et al. Hypoxia Downregulates LPP3 and Promotes the Spatial Segregation of ATX and LPP1 During Cancer Cell Invasion , 2019, Cancers.
[5] Wei Li,et al. The transcriptional factors HIF-1 and HIF-2 and their novel inhibitors in cancer therapy , 2019, Expert opinion on drug discovery.
[6] G. Reynolds,et al. Autotaxin-lysophosphatidic acid receptor signalling regulates hepatitis C virus replication. , 2017, Journal of hepatology.
[7] Y. Hoshida,et al. The autotaxin-lysophosphatidic acid pathway emerges as a therapeutic target to prevent liver cancer , 2017, Molecular & cellular oncology.
[8] Jin Zhang,et al. AHNAK2 is a Novel Prognostic Marker and Oncogenic Protein for Clear Cell Renal Cell Carcinoma , 2017, Theranostics.
[9] G. Mills,et al. Autotaxin, a lysophospholipase D with pleomorphic effects in oncogenesis and cancer progression , 2016, Journal of Lipid Research.
[10] Ming Guan,et al. Type I Interferons Function as Autocrine and Paracrine Factors to Induce Autotaxin in Response to TLR Activation , 2015, PloS one.
[11] C. Allis,et al. Intracellular crotonyl-CoA stimulates transcription through p300-catalyzed histone crotonylation. , 2015, Molecular cell.
[12] V. Aidinis,et al. Autotaxin, a secreted lysophospholipase D, as a promising therapeutic target in chronic inflammation and cancer. , 2015, Progress in lipid research.
[13] Carolyn J. Brown,et al. Hypoxia and environmental epigenetics. , 2014, High altitude medicine & biology.
[14] S. Georas,et al. The Autotaxin–LPA Axis Emerges as a Novel Regulator of Lymphocyte Homing and Inflammation , 2014, The Journal of Immunology.
[15] Joel I. Perez-Perri,et al. Epigenetics: New Questions on the Response to Hypoxia , 2011, International journal of molecular sciences.
[16] W. Wong,et al. Hypoxia-inducible factors and the response to hypoxic stress. , 2010, Molecular cell.
[17] U. Lendahl,et al. Generating specificity and diversity in the transcriptional response to hypoxia , 2009, Nature Reviews Genetics.
[18] H. Arai,et al. Serum lysophospholipase D/autotaxin may be a new nutritional assessment marker: study on prostate cancer patients , 2007, Annals of clinical biochemistry.
[19] G. Casey,et al. Reduced expression of autotaxin predicts survival in uveal melanoma , 2007, British Journal of Ophthalmology.
[20] K. Fukuzawa,et al. Peritoneal fluids from patients with certain gynecologic tumor contain elevated levels of bioactive lysophospholipase D activity. , 2007, Life sciences.
[21] Y. Kishi,et al. Autotaxin Is Overexpressed in Glioblastoma Multiforme and Contributes to Cell Motility of Glioblastoma by Converting Lysophosphatidylcholine TO Lysophosphatidic Acid* , 2006, Journal of Biological Chemistry.
[22] G. Semenza. Targeting HIF-1 for cancer therapy , 2003, Nature Reviews Cancer.
[23] D. Tarin,et al. Identification of genes associated with metastasis of mammary carcinoma in metastatic versus non-metastatic cell lines. , 2002, Anticancer research.
[24] P. Vaupel,et al. Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. , 2001, Journal of the National Cancer Institute.
[25] Suk Woo Nam,et al. Autotaxin (ATX), a potent tumor motogen, augments invasive and metastatic potential of ras-transformed cells , 2000, Oncogene.
[26] G. Semenza,et al. The human hypoxia-inducible factor 1alpha gene: HIF1A structure and evolutionary conservation. , 1998, Genomics.
[27] Y Fujii-Kuriyama,et al. A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1alpha regulates the VEGF expression and is potentially involved in lung and vascular development. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[28] W. Risau,et al. HRF, a putative basic helix-loop-helix-PAS-domain transcription factor is closely related to hypoxia-inducible factor-1α and developmentally expressed in blood vessels , 1997, Mechanisms of Development.
[29] J. Hogenesch,et al. Characterization of a Subset of the Basic-Helix-Loop-Helix-PAS Superfamily That Interacts with Components of the Dioxin Signaling Pathway* , 1997, The Journal of Biological Chemistry.
[30] G. Semenza,et al. In vivo expression of mRNAs encoding hypoxia-inducible factor 1. , 1996, Biochemical and biophysical research communications.
[31] G. Semenza,et al. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[32] H. Krutzsch,et al. Identification, purification, and partial sequence analysis of autotaxin, a novel motility-stimulating protein. , 1992, The Journal of biological chemistry.
[33] J. Saulnier-Blache,et al. Involvement of autotaxin/lysophosphatidic acid signaling in obesity and impaired glucose homeostasis. , 2014, Biochimie.
[34] S. McKnight,et al. Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells. , 1997, Genes & development.
[35] Kai-Uwe Eckardt,et al. The FASEB Journal express article 10.1096/fj.02-0445fje. Published online December 17, 2002. Widespread, hypoxia-inducible expression of HIF-2α in distinct cell populations of different organs , 2022 .